Tag Archives: Regulatory Affairs Professional Society

FDA Finalizes Biosimilar Guidance

The Regulatory Affairs Professional Society (RAPS) has posted an informative article “After Three-Year Delay, FDA Finalizes Guidance Documents on Biosimilarity.”  The article includes links to the final guidance documents. You can find the article here.

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment